Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
45
YARIY Quote, Financials, Valuation and Earnings
Last price:
$18.72
Seasonality move
:
6.09%
Day range:
$18.66 - $18.85
52-week range:
$12.98 - $20.31
Dividend yield:
1.32%
P/E ratio:
33.20x
P/S ratio:
0.68x
P/B ratio:
1.28x
Volume:
11.4K
Avg. volume:
15.3K
1-year change:
38.82%
Market cap:
$9.6B
Revenue:
$13.9B
EPS (TTM):
$0.57
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Yara International ASA has -- downside to fair value with a price target of -- per share.
YARIY vs. S&P 500
-
Over the past 5 trading days, Yara International ASA has underperformed the S&P 500 by -2.93% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Yara International ASA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Yara International ASA has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Yara International ASA reported revenues of $3.6B.
Earnings Growth
-
Yara International ASA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Yara International ASA reported earnings per share of $0.58.
Enterprise value:
12.9B
EV / Invested capital:
--
Price / LTM sales:
0.68x
EV / EBIT:
17.42x
EV / Revenue:
0.91x
PEG ratio (5yr expected):
--
EV / Free cash flow:
25.22x
Price / Operating cash flow:
18.77x
Enterprise value / EBITDA:
7.23x
Gross Profit (TTM):
$3.9B
Return On Assets:
1.84%
Net Income Margin (TTM):
2.05%
Return On Equity:
3.93%
Return On Invested Capital:
2.59%
Operating Margin:
7.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $22.1B | $14.7B | $14.2B | $3.3B | $3.6B | |
| Gross Profit | $5.7B | $3.4B | $3.9B | $869M | $1B | |
| Operating Income | $2.8B | $444M | $834M | $150M | $284M | |
| EBITDA | $3.8B | $1.4B | $1.8B | $386M | $691M | |
| Diluted EPS | $3.80 | -$0.08 | $0.57 | $0.04 | $0.58 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.6B | $9.1B | $8.2B | $6B | $6.1B | |
| Total Assets | $16.1B | $18.7B | $17.7B | $15.7B | $15.7B | |
| Current Liabilities | $3.2B | $6B | $3.9B | $3.5B | $3.2B | |
| Total Liabilities | $8.2B | $10.6B | $8.9B | $8.2B | $8.1B | |
| Total Equity | $8B | $8.1B | $8.7B | $7.4B | $7.5B | |
| Total Debt | $3.8B | $3.7B | $3.8B | $3.8B | $3.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.6B | $1.8B | $1.6B | $58M | $329M | |
| Cash From Investing | -$1B | -$1.2B | -$1B | -$294M | -$240M | |
| Cash From Financing | -$1B | -$1.4B | -$511M | $27M | -$83M | |
| Free Cash Flow | $1.6B | $704M | $511M | -$197M | $66M | |
YARIY
Sector
Market Cap
$9.6B
$19.1M
Price % of 52-Week High
92.68%
70.42%
Dividend Yield
1.32%
0%
Shareholder Yield
--
0.73%
1-Year Price Total Return
38.82%
-6.33%
Beta (5-Year)
0.905
0.736
Dividend yield:
1.32%
Annualized payout:
$0.24
Payout ratio:
41.38%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$18.97
200-day SMA
Buy
Level
$15.66
Bollinger Bands (100)
Buy
Level
14.87 - 18.49
Chaikin Money Flow
Buy
Level
37.5K
20-day SMA
Sell
Level
$18.88
Relative Strength Index (RSI14)
Buy
Level
52.37
ADX Line
Buy
Level
16.36
Williams %R
Neutral
Level
-41.8571
50-day SMA
Buy
Level
$18.28
MACD (12, 26)
Buy
Level
5.16
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Neutral
Level
37.5K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.6176)
Buy
CA Score
(Annual)
Level (-0.1193)
Buy
Beneish M-Score
(Annual)
Level (-3.0656)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.5367)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Yara International ASA is a Crop nutrition company, and developing low-emission energy solutions. The company converts natural gas into nitrogen products. It is engaged in the production of ammonia, mineral fertilizers, and industrial products. The firm also develops and markets environmental solutions and essential products for industrial applications. It markets and distributes a complete range of crop nutrition products and programs globally. Its operating segments are Europe, Americas, Africa & Asia, Global Plants & Operational Excellence, Clean Ammonia, and Industrial Solutions.
Stock Forecast FAQ
In the current month, YARIY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The YARIY average analyst price target in the past 3 months is --.
-
Where Will Yara International ASA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Yara International ASA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Yara International ASA?
Analysts are divided on their view about Yara International ASA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Yara International ASA is a Sell and believe this share price will rise from its current level to --.
-
What Is Yara International ASA's Price Target?
The price target for Yara International ASA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is YARIY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Yara International ASA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of YARIY?
You can purchase shares of Yara International ASA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Yara International ASA shares.
-
What Is The Yara International ASA Share Price Today?
Yara International ASA was last trading at $18.72 per share. This represents the most recent stock quote for Yara International ASA. Yesterday, Yara International ASA closed at $18.82 per share.
-
How To Buy Yara International ASA Stock Online?
In order to purchase Yara International ASA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
